Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil Therapy-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil Therapy

Published:2018-09-11 Issue:3 Volume:105 Page:598-613
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Beumer Jan H.¹²³,Chu Edward¹³,Allegra Carmen⁴,Tanigawara Yusuke⁵,Milano Gerard⁶,Diasio Robert⁷⁸,Kim Tae Won⁹,Mathijssen Ron H.¹⁰,Zhang Li¹¹,Arnold Dirk¹²,Muneoka Katsuki¹³,Boku Narikazu¹⁴,Joerger Markus¹⁵

Affiliation:

1. Cancer Therapeutics ProgramUPMC Hillman Cancer CenterPittsburgh Pennsylvania USA

2. Department of Pharmaceutical Sciences, School of PharmacyUniversity of PittsburghPittsburgh Pennsylvania USA

3. Division of Hematology‐Oncology, Department of MedicineUniversity of Pittsburgh School of MedicinePittsburgh Pennsylvania USA

4. University of FloridaGainesville Florida USA

5. Department of Clinical Pharmacokinetics and PharmacodynamicsKeio University School of MedicineTokyo Japan

6. Oncopharmacology UnitCentre Antoine LacassagneNice France

7. Developmental Therapeutics ProgramMayo Clinic Cancer CenterRochester Minnesota USA

8. Department of Molecular Pharmacology and Experimental TherapeuticsMayo Clinic School of MedicineRochester Minnesota USA

9. Department of OncologyUniversity of Ulsan College of Medicine, Asan Medical CenterSeoul Korea

10. Department of Medical OncologyErasmus MC Cancer Institute, Erasmus University Medical CenterRotterdam the Netherlands

11. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat‐Sen University Cancer CenterGuangzhou China

12. Department of Oncology, AK AltonaAsklepios Tumorzentrum HamburgHamburg Germany

13. Division of Oncology CenterNiitsu Medical Center HospitalNiigata City Japan

14. Department of Gastrointestinal Medical OncologyNational Cancer Center HospitalTsukiji, Chuo‐ku Tokyo Japan

15. Department of Medical Oncology & HematologyCantonal HospitalSt. Gallen Switzerland

Funder

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1124

Reference100 articles.

1. Flat-Fixed Dosing Versus Body Surface Area–Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference?

2. Without Therapeutic Drug Monitoring, There Is No Personalized Cancer Care

3. Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia

4. Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer

5. Clinical impact of pharmacokinetically‐guided dose adaptation of 5‐fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas;Fety R.;Clin. Cancer Res.,1998

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing DPYD Genotyping Method for Personalized Fluoropyrimidines Therapy;The Journal of Applied Laboratory Medicine;2023-12-12

2. Germlinecisvariant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD);2023-11-05

3. Semiconductor-based biosensor exploiting competitive adsorption with charged pseudo-target molecules for monitoring 5-fluorouracil concentration in human serum;Sensors and Actuators B: Chemical;2023-11

4. Therapeutic Drug Monitoring of 5-Fluorouracil in Head and Neck Cancer Patients: An Interventional Pilot Study;Indian Journal of Medical and Paediatric Oncology;2023-10-25

5. Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: From method development to clinical application;Journal of Pharmaceutical and Biomedical Analysis;2023-10